JP2013536864A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536864A5 JP2013536864A5 JP2013527286A JP2013527286A JP2013536864A5 JP 2013536864 A5 JP2013536864 A5 JP 2013536864A5 JP 2013527286 A JP2013527286 A JP 2013527286A JP 2013527286 A JP2013527286 A JP 2013527286A JP 2013536864 A5 JP2013536864 A5 JP 2013536864A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- crystalline form
- thrombosis
- item
- stroke
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37933910P | 2010-09-01 | 2010-09-01 | |
| US61/379,339 | 2010-09-01 | ||
| US201161454396P | 2011-03-18 | 2011-03-18 | |
| US61/454,396 | 2011-03-18 | ||
| PCT/US2011/050057 WO2012031017A1 (en) | 2010-09-01 | 2011-08-31 | CRYSTALLINE FORMS OF A FACTOR Xa INHIBITOR |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015187427A Division JP2015232046A (ja) | 2010-09-01 | 2015-09-24 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2017221050A Division JP2018024709A (ja) | 2010-09-01 | 2017-11-16 | 第Ｘａ因子阻害剤の結晶形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013536864A JP2013536864A (ja) | 2013-09-26 |
| JP2013536864A5 true JP2013536864A5 (enExample) | 2014-10-09 |
Family
ID=45773260
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013527286A Pending JP2013536864A (ja) | 2010-09-01 | 2011-08-31 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2015187427A Pending JP2015232046A (ja) | 2010-09-01 | 2015-09-24 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2017221050A Pending JP2018024709A (ja) | 2010-09-01 | 2017-11-16 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2019081907A Pending JP2019135258A (ja) | 2010-09-01 | 2019-04-23 | 第Ｘａ因子阻害剤の結晶形態 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015187427A Pending JP2015232046A (ja) | 2010-09-01 | 2015-09-24 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2017221050A Pending JP2018024709A (ja) | 2010-09-01 | 2017-11-16 | 第Ｘａ因子阻害剤の結晶形態 |
| JP2019081907A Pending JP2019135258A (ja) | 2010-09-01 | 2019-04-23 | 第Ｘａ因子阻害剤の結晶形態 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8946269B2 (enExample) |
| EP (1) | EP2611779B1 (enExample) |
| JP (4) | JP2013536864A (enExample) |
| CN (1) | CN103261161B (enExample) |
| AR (1) | AR082804A1 (enExample) |
| AU (1) | AU2011295909B2 (enExample) |
| CA (1) | CA2810004C (enExample) |
| ES (1) | ES2603084T3 (enExample) |
| IL (1) | IL224698A (enExample) |
| NZ (1) | NZ608442A (enExample) |
| PT (1) | PT2611779T (enExample) |
| TW (1) | TW201221128A (enExample) |
| WO (1) | WO2012031017A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980876B2 (en) | 2010-10-28 | 2015-03-17 | The Procter & Gamble Company | Inhibition of microbial growth by aconitase inhibition |
| WO2013033370A1 (en) | 2011-08-31 | 2013-03-07 | Portola Pharmaceuticals, Inc. | Prevention and treatment of thrombosis in medically ill patients |
| JP6227878B2 (ja) * | 2012-03-16 | 2017-11-08 | ラクステラ・インコーポレイテッドＬｕｘｔｅｒａ，Ｉｎｃ． | 光インターポーザのための方法及びシステム |
| US9200268B2 (en) | 2012-12-27 | 2015-12-01 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
| US20140346397A1 (en) | 2012-12-27 | 2014-11-27 | Portola Pharmaceuticals, Inc. | Compounds and methods for purification of serine proteases |
| CN104693114B (zh) * | 2013-12-10 | 2019-08-16 | 四川海思科制药有限公司 | 一种贝曲西班的改进的制备方法 |
| CN105085387A (zh) * | 2014-05-20 | 2015-11-25 | 四川海思科制药有限公司 | 贝曲西班盐及其制备方法和用途 |
| WO2017091757A1 (en) | 2015-11-24 | 2017-06-01 | Portola Pharmaceuticals, Inc. | Isotopically enriched betrixaban |
| CN106995405A (zh) * | 2016-01-25 | 2017-08-01 | 重庆医药工业研究院有限责任公司 | 一种贝曲西班马来酸盐无定型物及其制备方法 |
| US20190300483A1 (en) * | 2016-06-02 | 2019-10-03 | Dr. Reddy's Laboratories Limited | POLYMORPHS OF BETRlXABAN & ITS MALEATE SALT |
| EP3254674A1 (en) | 2016-06-08 | 2017-12-13 | Sandoz Ag | Pharmaceutical compositions of betrixaban maleate |
| EP3293174A1 (en) | 2016-09-09 | 2018-03-14 | Sandoz Ag | Crystalline salts of betrixaban |
| WO2018069936A1 (en) | 2016-10-13 | 2018-04-19 | Mylan Laboratories Limited | Polymorphs and solid dispersion of betrixaban and methods for the preparation thereof |
| CN107382897B (zh) * | 2017-07-10 | 2021-05-04 | 浙江宏元药业股份有限公司 | 一种贝曲西班的中间体及其制备方法和应用 |
| EP3510996A1 (en) * | 2018-01-11 | 2019-07-17 | Sandoz AG | Pharmaceutical compositions of betrixaban |
| CN108570003A (zh) * | 2018-06-01 | 2018-09-25 | 浙江宏元药业股份有限公司 | 一种贝曲西班马来酸盐的一水无定形及其制备方法 |
| CN113905715B (zh) | 2019-06-28 | 2025-04-15 | 宝洁公司 | 光增强处理方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226238D0 (en) | 1992-12-16 | 1993-02-10 | Scherer Ltd R P | Encapsulation apparatus and process |
| US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
| US6844367B1 (en) | 1999-09-17 | 2005-01-18 | Millennium Pharmaceuticals, Inc. | Benzamides and related inhibitors of factor Xa |
| MXPA02006660A (es) * | 2000-01-07 | 2002-12-13 | Transform Pharmaceuticals Inc | Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento. |
| AU2001245353A1 (en) | 2000-02-29 | 2001-09-12 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| US6627646B2 (en) | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| DE10322469A1 (de) | 2003-05-19 | 2004-12-16 | Bayer Healthcare Ag | Heterocyclische Verbindungen |
| US7696352B2 (en) | 2004-06-18 | 2010-04-13 | Millennium Pharmaceuticals, Inc. | Factor Xa inhibitors |
| CN1968922A (zh) | 2004-06-18 | 2007-05-23 | 米伦纽姆医药公司 | 因子xa抑制剂 |
| KR101358574B1 (ko) * | 2005-11-08 | 2014-02-04 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | Ｘａ 인자 억제제, ｎ（5클로로2피리디닐）2［［4［（디메틸아미노）이미노메틸］벤조일］아미노］5메톡시벤자마이드의 약제학적 염 및 다형체 |
| TW200813017A (en) | 2006-05-05 | 2008-03-16 | Millennium Pharm Inc | Factor XA inhibitors |
| US20080051578A1 (en) | 2006-08-24 | 2008-02-28 | Georg Dahmann | Substituted biaryls, process for their manufacture and use thereof as medicaments |
| PT2404906E (pt) | 2006-11-02 | 2015-11-02 | Millennium Pharm Inc | Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa |
| CA2913963A1 (en) | 2006-12-08 | 2008-06-19 | Millenium Pharmaceuticals, Inc. | Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor |
| EP2114930A2 (en) | 2007-01-05 | 2009-11-11 | Millennium Pharmaceuticals, Inc. | Factor xa inhibitors |
| AU2008239659B2 (en) | 2007-04-13 | 2013-09-05 | Millennium Pharmaceuticals, Inc. | Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitor |
| EP2586439A1 (en) * | 2007-05-02 | 2013-05-01 | Portola Pharmaceuticals, Inc. | Combination therapy with a compound acting as a platelet ADP receptor inhibitor |
| SI2915564T1 (sl) | 2007-09-28 | 2021-03-31 | Alexion Pharmaceuticals, Inc. | Antidoti za zaviralce dejavnika Ksa in postopki njihove uporabe |
| US8455439B2 (en) * | 2008-11-14 | 2013-06-04 | Portola Pharmaceuticals, Inc. | Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agents |
| JP5766204B2 (ja) | 2009-12-17 | 2015-08-19 | ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 第Ｘａ因子阻害剤の合成方法 |
| AR082803A1 (es) | 2010-09-01 | 2013-01-09 | Portola Pharm Inc | Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p |
-
2011
- 2011-08-30 AR ARP110103159A patent/AR082804A1/es unknown
- 2011-08-30 TW TW100131157A patent/TW201221128A/zh unknown
- 2011-08-31 PT PT117574673T patent/PT2611779T/pt unknown
- 2011-08-31 ES ES11757467.3T patent/ES2603084T3/es active Active
- 2011-08-31 CA CA2810004A patent/CA2810004C/en not_active Expired - Fee Related
- 2011-08-31 NZ NZ60844211A patent/NZ608442A/en not_active IP Right Cessation
- 2011-08-31 US US13/223,023 patent/US8946269B2/en active Active
- 2011-08-31 AU AU2011295909A patent/AU2011295909B2/en not_active Ceased
- 2011-08-31 CN CN201180052042.4A patent/CN103261161B/zh not_active Expired - Fee Related
- 2011-08-31 JP JP2013527286A patent/JP2013536864A/ja active Pending
- 2011-08-31 WO PCT/US2011/050057 patent/WO2012031017A1/en not_active Ceased
- 2011-08-31 EP EP11757467.3A patent/EP2611779B1/en not_active Not-in-force
-
2013
- 2013-02-13 IL IL224698A patent/IL224698A/en active IP Right Grant
-
2015
- 2015-09-24 JP JP2015187427A patent/JP2015232046A/ja active Pending
-
2017
- 2017-11-16 JP JP2017221050A patent/JP2018024709A/ja active Pending
-
2019
- 2019-04-23 JP JP2019081907A patent/JP2019135258A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536864A5 (enExample) | ||
| JP5416408B2 (ja) | ５−クロロ−ｎ−（｛（５ｓ）−２−オキソ−３−［４−（３−オキソ−４−モルホリニル）−フェニル］−１，３−オキサゾリジン−５−イル｝−メチル）−２−チオフェンカルボキサミドの新規多形および無定形 | |
| DK2906551T3 (en) | CRYSTALLIC FORMS OF A FACTOR XIA INHIBITOR | |
| TWI393715B (zh) | 作為組織胺ｈ3受體調節劑之經取代的吡啶基醯胺化合物 | |
| RU2443688C2 (ru) | ПРОИЗВОДНЫЕ ИЗОХИНОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ | |
| TWI358296B (en) | Acid secretion inhibitor | |
| CN105324117B (zh) | 作为丝氨酸蛋白酶抑制剂的多取代芳族化合物 | |
| RU2008123055A (ru) | СОЛИ ИНГИБИТОРА ФАКТОРА Ха, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ТРОМБОЗА И СПОСОБ ИНГИБИРОВАНИЯ КОАГУЛЯЦИИ ОБРАЗЦОВ КРОВИ | |
| JP2009514976A5 (enExample) | ||
| JP2019135258A (ja) | 第Ｘａ因子阻害剤の結晶形態 | |
| DK3009426T3 (en) | 4-ALKYNYL-IMIDAZOLE DERIVATIVE AND MEDICINE COMPREHENSIVE AS AN ACTIVE INGREDIENT | |
| WO2012102297A1 (ja) | ピラゾロピリジン誘導体、またはその薬理学的に許容される塩 | |
| JP5336359B2 (ja) | テトラヒドロイソキノリン−１−オン誘導体またはその塩 | |
| EP2138482A1 (en) | Bicyclic heterocyclic compound | |
| JP2005047927A (ja) | 純結晶形態の５−クロロ−３−（４−メタンスルホニルフェニル）−６’−メチル−［２，３’］ビピリジニルおよび合成方法 | |
| MX2010012067A (es) | Derivados de 3,4-piperidina sustituida como inhibidores de la renina. | |
| JP2007533672A (ja) | ＴＡＦＩａ阻害剤として用いるイミダゾール誘導体 | |
| WO2013107285A1 (zh) | 氨基杂芳基化合物及其制备方法与应用 | |
| US20080188517A1 (en) | Crystalline forms of a factor xa inhibitor | |
| TWI236470B (en) | Cyclic diamine compounds bearing six-membered cyclic groups | |
| JP2009525311A (ja) | 新規なピリジニルアミノアルキレン−およびピリジニルオキシアルキレン−シクロプロパンアミン類、それらの製造方法ならびにそれらを含有する医薬組成物 | |
| JP4719744B2 (ja) | カリウムチャンネル阻害剤 | |
| TW200922586A (en) | Thiophene 1,2,4-triazole derivatives as modulators of mGluR5 | |
| RU2373206C2 (ru) | Соединение имидазопиридина | |
| JP2011515491A5 (enExample) |